Skip to main content

Advertisement

Log in

Regional cerebral perfusion in patients with amnestic mild cognitive impairment: effect of cerebral small vessel disease

  • Original Article
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Objective

To explore the effort of cerebral small vessel disease (CSVD) on regional cerebral perfusion in patients with mild cognitive impairment (MCI) using NeuroGam™ software and evaluate the capability of brain perfusion single photon emission computed tomography (SPECT) in distinguishing MCI with and without CSVD.

Methods

34 amnestic MCI subjects entered this study, conducting neuropsychological tests, MRI and 99mTechnetium ethyl cystine dimer brain perfusion SPECT imaging. All subjects were divided into those with CSVD and those without CSVD. Perfusion value was measured with Brodmann area (BA) mapping in these two groups. Automated software (NeuroGam™) was used for semi-quantitative analyses of perfusion value and comparison with normal database.

Results

Compared with normal database, perfusion levels in BAs 23-left, 28 and 36-left of MCI without CSVD group had great deviations, while perfusion levels in BAs 21, 23, 24, 25, 28, 36, 38 and 47-left of MCI with CSVD group had great deviations. Furthermore, compared with CSVD group, there was significantly lower perfusion value in BA 7-left (P < 0.001) in MCI without CSVD group.

Conclusions

CSVD could interact with pathological changes related to AD, exacerbating hypoperfusion in BAs 21, 23, 28, 36, 38 while compensating for cerebral blood perfusion disorder in BA 7-left in MCI patients. Meanwhile, MCI patients with CSVD shared similar hypoperfusion with vascular cognitive impairment (VCI) in BAs 24, 25 and 47L. Brain perfusion SPECT may help improve our ability to differentiate MCI with and without CSVD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Du J, Zhu H, Zhou J, Lu P, Qiu Y, Yu L, et al. Structural brain network disruption at preclinical stage of cognitive impairment due to cerebral small vessel disease. Neuroscience. 2020;449:99–115.

    Article  CAS  Google Scholar 

  2. Li K, Fu Z, Luo X, Zeng Q, Huang P, Zhang M, et al. The influence of cerebral small vessel disease on static and dynamic functional network connectivity in subjects Along Alzheimer’s disease continuum. Brain Connect. 2021;11(3):189–200.

    Article  Google Scholar 

  3. Pantoni L, Marzi C, Poggesi A, Giorgio A, De Stefano N, Mascalchi M, et al. Fractal dimension of cerebral white matter: a consistent feature for prediction of the cognitive performance in patients with small vessel disease and mild cognitive impairment. Neuroimage Clin. 2019;24: 101990.

    Article  Google Scholar 

  4. Lee MJ, Seo SW, Na DL, Kim C, Park JH, Kim GH, et al. Synergistic effects of ischemia and β-amyloid burden on cognitive decline in patients with subcortical vascular mild cognitive impairment. JAMA Psychiat. 2014;71(4):412–22.

    Article  Google Scholar 

  5. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):270–9.

    Article  Google Scholar 

  6. Liu R, Chen H, Qin R, Gu Y, Chen X, Zou J, et al. The altered reconfiguration pattern of brain modular architecture regulates cognitive function in cerebral small vessel disease. Front Neurol. 2019;10:324.

    Article  Google Scholar 

  7. Fazekas F, Barkhof F, Wahlund LO, Pantoni L, Erkinjuntti T, Scheltens P, et al. CT and MRI rating of white matter lesions. Cerebrovasc Dis. 2002;13(Suppl 2):31–6.

    Article  Google Scholar 

  8. Staals J, Makin SD, Doubal FN, Dennis MS, Wardlaw JM. Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology. 2014;83(14):1228–34.

    Article  Google Scholar 

  9. Valotassiou V, Papatriantafyllou J, Sifakis N, Tzavara C, Tsougos I, Kapsalaki E, et al. Perfusion SPECT studies with mapping of Brodmann areas in differentiating Alzheimer’s disease from frontotemporal degeneration syndromes. Nucl Med Commun. 2012;33(12):1267–76.

    Article  Google Scholar 

  10. Habert MO, Horn JF, Sarazin M, Lotterie JA, Puel M, Onen F, et al. Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer’s disease among patients with mild cognitive impairment. Neurobiol Aging. 2011;32(1):15–23.

    Article  Google Scholar 

  11. Valotassiou V, Papatriantafyllou J, Sifakis N, Tzavara C, Tsougos I, Psimadas D, et al. Clinical evaluation of brain perfusion SPECT with Brodmann areas mapping in early diagnosis of Alzheimer’s disease. J Alzheimers Dis. 2015;47(3):773–85.

    Article  Google Scholar 

  12. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239–59.

    Article  CAS  Google Scholar 

  13. Cho H, Choi JY, Hwang MS, Lee JH, Kim YJ, Lee HM, et al. Tau PET in Alzheimer disease and mild cognitive impairment. Neurology. 2016;87(4):375–83.

    Article  CAS  Google Scholar 

  14. Zhou M, Zhang F, Zhao L, Qian J, Dong C. Entorhinal cortex: a good biomarker of mild cognitive impairment and mild Alzheimer’s disease. Rev Neurosci. 2016;27(2):185–95.

    Article  Google Scholar 

  15. Vogt BA, Finch DM, Olson CR. Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regions. Cereb Cortex. 1992;2(6):435–43.

    CAS  PubMed  Google Scholar 

  16. Johnson KA, Moran EK, Becker JA, Blacker D, Fischman AJ, Albert MS. Single photon emission computed tomography perfusion differences in mild cognitive impairment. J Neurol Neurosurg Psychiatry. 2007;78(3):240–7.

    Article  CAS  Google Scholar 

  17. Hirao K, Ohnishi T, Matsuda H, Nemoto K, Hirata Y, Yamashita F, et al. Functional interactions between entorhinal cortex and posterior cingulate cortex at the very early stage of Alzheimer’s disease using brain perfusion single-photon emission computed tomography. Nucl Med Commun. 2006;27(2):151–6.

    Article  Google Scholar 

  18. Eichenbaum H, Schoenbaum G, Young B, Bunsey M. Functional organization of the hippocampal memory system. Proc Natl Acad Sci USA. 1996;93(24):13500–7.

    Article  CAS  Google Scholar 

  19. Mosconi L, Pupi A, De Cristofaro MT, Fayyaz M, Sorbi S, Herholz K. Functional interactions of the entorhinal cortex: an 18F-FDG PET study on normal aging and Alzheimer’s disease. J Nucl Med. 2004;45(3):382–92.

    PubMed  Google Scholar 

  20. Liu J, Zhang X, Yu C, Duan Y, Zhuo J, Cui Y, et al. Impaired parahippocampus connectivity in mild cognitive impairment and Alzheimer’s disease. J Alzheimers Dis. 2016;49(4):1051–64.

    Article  Google Scholar 

  21. Grau-Olivares M, Arboix A. Mild cognitive impairment in stroke patients with ischemic cerebral small-vessel disease: a forerunner of vascular dementia? Expert Rev Neurother. 2009;9(8):1201–17.

    Article  Google Scholar 

  22. Kim HJ, Park S, Cho H, Jang YK, San Lee J, Jang H, et al. Assessment of extent and role of tau in subcortical vascular cognitive impairment using 18F-AV1451 positron emission tomography imaging. JAMA Neurol. 2018;75(8):999–1007.

    Article  Google Scholar 

  23. Wong FCC, Yatawara C, Low A, Foo H, Wong BYX, Lim L, et al. Cerebral small vessel disease influences hippocampal subfield atrophy in mild cognitive impairment. Transl Stroke Res. 2021;12(2):284–92.

    Article  Google Scholar 

  24. Meguro K, Dodge HH. Vascular mild cognitive impairment: identifying disease in community-dwelling older adults, reducing risk factors, and providing support. The Osaki-Tajiri and Kurihara Projects. J Alzheimers Dis. 2019;70(s1):S293-s302.

    Article  Google Scholar 

  25. Wang J, Liang Y, Chen H, Wang W, Wang Y, Liang Y, et al. Structural changes in white matter lesion patients and their correlation with cognitive impairment. Neuropsychiatr Dis Treat. 2019;15:1355–63.

    Article  Google Scholar 

  26. Japee S, Holiday K, Satyshur MD, Mukai I, Ungerleider LG. A role of right middle frontal gyrus in reorienting of attention: a case study. Front Syst Neurosci. 2015;9:23.

    Article  Google Scholar 

  27. Zhou X, Hu X, Zhang C, Wang H, Zhu X, Xu L, et al. Aberrant functional connectivity and structural atrophy in subcortical vascular cognitive impairment: relationship with cognitive impairments. Front Aging Neurosci. 2016;8:14.

    PubMed  PubMed Central  Google Scholar 

  28. Cavanna AE, Trimble MR. The precuneus: a review of its functional anatomy and behavioural correlates. Brain. 2006;129(Pt 3):564–83.

    Article  Google Scholar 

  29. Borroni B, Anchisi D, Paghera B, Vicini B, Kerrouche N, Garibotto V, et al. Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD. Neurobiol Aging. 2006;27(1):24–31.

    Article  CAS  Google Scholar 

  30. Buckner RL, Andrews-Hanna JR, Schacter DL. The brain’s default network: anatomy, function, and relevance to disease. Ann NY Acad Sci. 2008;1124:1–38.

    Article  Google Scholar 

  31. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9(7):689–701.

    Article  Google Scholar 

  32. Lawrence AJ, Chung AW, Morris RG, Markus HS, Barrick TR. Structural network efficiency is associated with cognitive impairment in small-vessel disease. Neurology. 2014;83(4):304–11.

    Article  CAS  Google Scholar 

  33. Liu C, Zou L, Tang X, Zhu W, Zhang G, Qin Y, et al. Changes of white matter integrity and structural network connectivity in nondemented cerebral small-vessel disease. J Magn Reson Imaging. 2020;51(4):1162–9.

    Article  CAS  Google Scholar 

  34. Chen W, Song X, Beyea S, D’Arcy R, Zhang Y, Rockwood K. Advances in perfusion magnetic resonance imaging in Alzheimer’s disease. Alzheimers Dement. 2011;7(2):185–96.

    Article  Google Scholar 

  35. Jacobs KM. Brodmann’s areas of the cortex. New York: Springer; 2011.

    Book  Google Scholar 

Download references

Acknowledgements

This study was supported by Shanghai Science and Technology Commission Project: Molecular imaging study on mild cognitive impairment (No. 17411950102) and National Key Research and Development Plan Digital Diagnosis and Treatment Equipment Research and Development Project: Research and Practice of PET-CT Comprehensive Evaluation System and Training System (No. 2017YFC0113300).

Funding

Shanghai Science and Technology Commission Project: Molecular imaging study on mild cognitive impairment (No. 17411950102) and National Key Research and Development Plan Digital Diagnosis and Treatment Equipment Research and Development Project: Research and Practice of PET-CT Comprehensive Evaluation System and Training System (No. 2017YFC0113300).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xingdang Liu.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lei, Z., Lou, J., Wu, H. et al. Regional cerebral perfusion in patients with amnestic mild cognitive impairment: effect of cerebral small vessel disease. Ann Nucl Med 36, 43–51 (2022). https://doi.org/10.1007/s12149-021-01682-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-021-01682-9

Keywords

Navigation